Mingnan Chen

1.5k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Mingnan Chen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mingnan Chen has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Mingnan Chen's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (5 papers) and vaccines and immunoinformatics approaches (5 papers). Mingnan Chen is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (5 papers) and vaccines and immunoinformatics approaches (5 papers). Mingnan Chen collaborates with scholars based in United States, China and Japan. Mingnan Chen's co-authors include Jonathan R. McDaniel, Ashutosh Chilkoti, J. Andrew MacKay, Andrew J. Simnick, Wenge Liu, Marlène Bouvier, Peng Zhao, Shuyun Dong, Jin Zhang and Xiao He and has published in prestigious journals such as Nature Materials, The EMBO Journal and Biomaterials.

In The Last Decade

Mingnan Chen

25 papers receiving 1.2k citations

Hit Papers

Self-assembling chimeric ... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection
    2009 500 citations J. Andrew MacKay, Mingnan Chen et al. Nature Materials profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mingnan Chen 531 506 329 297 226 26 1.2k
Tracie Delgado 660 1.2× 333 0.7× 233 0.7× 235 0.8× 278 1.2× 11 1.5k
R G Vile 385 0.7× 490 1.0× 190 0.6× 338 1.1× 250 1.1× 18 1.0k
Huizi Sha 577 1.1× 245 0.5× 277 0.8× 309 1.0× 401 1.8× 41 1.1k
John‐Michael Williford 473 0.9× 312 0.6× 342 1.0× 347 1.2× 302 1.3× 11 1.2k
Shabnum Patel 455 0.9× 251 0.5× 249 0.8× 227 0.8× 273 1.2× 27 1.1k
Thomas Schluep 1.2k 2.3× 645 1.3× 216 0.7× 453 1.5× 192 0.8× 47 2.6k
Youjia Cao 622 1.2× 174 0.3× 386 1.2× 216 0.7× 221 1.0× 57 1.5k
Lorena Simón‐Gracia 630 1.2× 380 0.8× 301 0.9× 322 1.1× 172 0.8× 36 1.2k
Aaron P. Griset 498 0.9× 384 0.8× 345 1.0× 288 1.0× 112 0.5× 13 1.3k
Meir Goldsmith 1.4k 2.6× 455 0.9× 462 1.4× 391 1.3× 170 0.8× 35 2.0k

Countries citing papers authored by Mingnan Chen

Since Specialization
Citations

This map shows the geographic impact of Mingnan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingnan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingnan Chen more than expected).

Fields of papers citing papers by Mingnan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingnan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingnan Chen. The network helps show where Mingnan Chen may publish in the future.

Co-authorship network of co-authors of Mingnan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingnan Chen. A scholar is included among the top collaborators of Mingnan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingnan Chen. Mingnan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Shuyun, Tianxiao Zhang, Yujia Zhai, et al.. (2025). 3-in-one PD-1CAR Tregs: A bioengineered cellular therapy for target engagement, activation, and immunosuppression with reparative potential. iScience. 28(11). 113677–113677.
3.
Dong, Shuyun, et al.. (2024). Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatment. Acta Pharmaceutica Sinica B. 15(3). 1230–1241. 2 indexed citations
4.
Zhai, Yujia, Shuyun Dong, Haojia Li, et al.. (2022). Antibody-mediated depletion of programmed death 1-positive (PD-1+) cells. Journal of Controlled Release. 349. 425–433. 2 indexed citations
5.
Zhai, Yujia, et al.. (2021). Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases. Frontiers in Immunology. 12. 645699–645699. 25 indexed citations
6.
Dong, Shuyun, Sundharraman Subramanian, Kristin N. Parent, & Mingnan Chen. (2020). Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity. Journal of Controlled Release. 328. 653–664. 2 indexed citations
7.
Zhao, Peng, Peng Wang, Shuyun Dong, et al.. (2019). Depletion of PD-1-positive cells ameliorates autoimmune disease. Nature Biomedical Engineering. 3(4). 292–305. 58 indexed citations
8.
9.
Wang, Peng, Shuyun Dong, Peng Zhao, Xiao He, & Mingnan Chen. (2018). Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo. Biomaterials. 182. 92–103. 12 indexed citations
10.
Wang, Peng, Peng Zhao, Shuyun Dong, et al.. (2017). An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells. Theranostics. 8(1). 223–236. 28 indexed citations
11.
Dong, Shuyun, Tiefeng Xu, Peng Wang, Peng Zhao, & Mingnan Chen. (2017). Engineering of a self-adjuvanted iTEP-delivered CTL vaccine. Acta Pharmacologica Sinica. 38(6). 914–923. 6 indexed citations
12.
13.
Dong, Shuyun, Tiefeng Xu, Peng Zhao, Kristin N. Parent, & Mingnan Chen. (2016). A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the Carriers. Theranostics. 6(5). 666–678. 9 indexed citations
14.
Mastria, Eric M., Mingnan Chen, Jonathan R. McDaniel, et al.. (2015). Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma. Journal of Controlled Release. 208. 52–58. 48 indexed citations
15.
Zhang, Jin, et al.. (2014). Gene-Directed Enzyme Prodrug Therapy. The AAPS Journal. 17(1). 102–110. 117 indexed citations
16.
Chen, Mingnan, Jonathan R. McDaniel, J. Andrew MacKay, & Ashutosh Chilkoti. (2011). NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS. Technology & Innovation. 13(1). 5–25. 4 indexed citations
17.
Liu, Wenge, J. Andrew MacKay, Matthew R. Dreher, et al.. (2010). Injectable intratumoral depot of thermally responsive polypeptide–radionuclide conjugates delays tumor progression in a mouse model. Journal of Controlled Release. 144(1). 2–9. 81 indexed citations
18.
MacKay, J. Andrew, Mingnan Chen, Jonathan R. McDaniel, et al.. (2009). Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nature Materials. 8(12). 993–999. 500 indexed citations breakdown →
19.
Sadegh‐Nasseri, Scheherazade, Mingnan Chen, Kedar Narayan, & Marlène Bouvier. (2008). The convergent roles of tapasin and HLA-DM in antigen presentation. Trends in Immunology. 29(3). 141–147. 33 indexed citations
20.
Chen, Mingnan & Marlène Bouvier. (2007). Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. The EMBO Journal. 26(6). 1681–1690. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracie Delgado Breakdown of academic impact, for papers by R G Vile Breakdown of academic impact, for papers by Huizi Sha Breakdown of academic impact, for papers by John‐Michael Williford Breakdown of academic impact, for papers by Shabnum Patel Breakdown of academic impact, for papers by Thomas Schluep Breakdown of academic impact, for papers by Youjia Cao Breakdown of academic impact, for papers by Lorena Simón‐Gracia Breakdown of academic impact, for papers by Aaron P. Griset Breakdown of academic impact, for papers by Meir Goldsmith
Rankless by CCL
2026